Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma

A. Loglio, M. Viganò, G. Grossi, S. Labanca, M. Goldaniga, A. Pompa, L. Farina, M. Rumi, P. Corradini, F. Facchetti, G. Lunghi, L. Baldini, P. Lampertico

Research output: Contribution to journalArticlepeer-review

Cite this